RESUMEN
Prehospital analgesia is vital to good clinical care and inhaled methoxyflurane (Penthrox) would be a valuable addition to the armed forces medical armoury. Penthrox would provide strong, fast-acting, self-administered and safe analgesia to patients with moderate to severe injuries. In addition, it would provide an option for strong analgesia which would not be subject to the regulations that govern controlled or accountable drugs which gives it a unique position as the military moves its focus from large enduring operations to small short-term training teams supported by lone combat medics in remote locations across the globe.
Asunto(s)
Analgesia/normas , Servicios Médicos de Urgencia/tendencias , Metoxiflurano/farmacología , Analgesia/métodos , Analgesia/tendencias , Anestésicos por Inhalación/administración & dosificación , Anestésicos por Inhalación/farmacología , Anestésicos por Inhalación/uso terapéutico , Servicios Médicos de Urgencia/métodos , Humanos , Metoxiflurano/administración & dosificación , Metoxiflurano/uso terapéutico , Manejo del Dolor/métodos , Manejo del Dolor/normas , Manejo del Dolor/estadística & datos numéricos , Dimensión del Dolor/métodos , Reino UnidoRESUMEN
Analgesia for battlefield war wound is the beginning of the war wound analgesia management system, and effective analgesia for battlefield war wound plays a significant role in keeping the fighting capacity. Special combat is characterized by the complexity and diversity of combat tasks, small scale of combat units, and limited medical service, resulting in a high incidence of war trauma. Therefore, the battlefield war wound analgesia for special combat personnel has prominent demands. In this paper, we analyzed the characteristics and current situation of battlefield war wound analgesia for special combat personnel, and discussed how to effectively carry out battlefield war wound analgesia, so as to provide reference for improving the fighting capacity of special combat personnel.